- Published on
CHRONIC FATIGUE SYNDROME
BASICS DESCRIPTION: Chronic fatigue syndrome (CFS) is a diverse condition that causes extreme, incapacitating fatigue that lasts for at least six months.
Considerations for Children
• Seldom seen in kids.
• As the counterpart of an adult handicap, absenteeism from activities or school should be tracked.
The study of epidemiology
In the US, the prevalence ranges from 4.0 to 8.7 per 100,000 (2). • Prevalence: 0.6–1% globally.
RISK ELEMENTS
Gender: women are 2-3 times more likely to have it. Genetics
ongoing investigation to see if any particular genes are connected to CFS.
Pathophysiology
Not sure.
ETIOLOGY: Unknown.
• There have been hypothesized but unsubstantiated correlations with EBV, CMV, HHV, HCV, Borrelia burgdorferi, and Brucella.
• Possible links to immunological or neuroendocrine conditions, including those involving the autonomic nervous system or the hypothalamic-pituitary-adrenal axis.
COMMON CONNECTED CIRCUMSTANCES
Depressive symptoms and fibromyalgia
History of Diagnosis
• Severe exhaustion that has persisted for over six months and has not gone away with rest.
• Four of the symptoms listed below:
Post-exercise malaise: Sleep that doesn't alleviate weariness
A diminished capacity for memory or focus
Muscle pain; joint pain in several places without heat or swelling; cervical or axillary lymph node pain; sore throat; headache
PHYSICAL EXAMINATION: Although it is possible, painful lymphadenopathy is not necessary for diagnosis.
• Minimal outward signs.
TESTS FOR DIAGNOSIS AND INTERPRETATION
Lab
as required to take into account additional causes of weariness.
Imagining
Not advised.
Diagnostic Techniques and Other
clinical history-based diagnosis of exclusion, in accordance with the 1994 CDC criteria.
There are no pathological findings.
DIFFERENTIAL DIAGNOSIS: Lyme disease, depression, epilepsy, brucellosis, CMV, Epstein-Barr virus, and HIV infection
Brain tumors, tumors with paraneoplastic syndrome, and collagen-vascular diseases
MEDICAL CARE
supportive actions listed below.
MEDICATION Antidepressants along with other forms of treatment.
ADDITIONAL MEDICATION
Overall Actions
a focus on several treatment approaches with the aim of gradual progress over time.
Other Treatments
CBT, or cognitive behavioral treatment, is one (1) example.
A regimen called graded exercise treatment helps people with CFS avoid the "push-crash" cycle, which is characterized by overexertion followed by post-exertional malaise.
Throughout the day, schedule shorter bursts of moderate activity to lower the risk of "push-
crash" cycle. combines exercise and cognitive behavioral therapy. • Good sleep habits.
• Research on sleep.
ALTERNATIVE AND COMPLIMENTARY THERAPIES
• Deep breathing and other relaxing methods; • Massage Tai chi, yoga, and healing touch
Continuing Care Follow-Up Suggestions
It is advised to follow up with a multidisciplinary team of providers on a regular basis.
PROGNOSIS
• It takes a long time to get diagnosed (around five years on average). • Symptom improvement: 6–63%.
• Symptom resolution: 0–37%.
BASICS DESCRIPTION: Chronic fatigue syndrome (CFS) is a diverse condition that causes extreme, incapacitating fatigue that lasts for at least six months.
Considerations for Children
• Seldom seen in kids.
• As the counterpart of an adult handicap, absenteeism from activities or school should be tracked.
The study of epidemiology
In the US, the prevalence ranges from 4.0 to 8.7 per 100,000 (2). • Prevalence: 0.6–1% globally.
RISK ELEMENTS
Gender: women are 2-3 times more likely to have it. Genetics
ongoing investigation to see if any particular genes are connected to CFS.
Pathophysiology
Not sure.
ETIOLOGY: Unknown.
• There have been hypothesized but unsubstantiated correlations with EBV, CMV, HHV, HCV, Borrelia burgdorferi, and Brucella.
• Possible links to immunological or neuroendocrine conditions, including those involving the autonomic nervous system or the hypothalamic-pituitary-adrenal axis.
COMMON CONNECTED CIRCUMSTANCES
Depressive symptoms and fibromyalgia
History of Diagnosis
• Severe exhaustion that has persisted for over six months and has not gone away with rest.
• Four of the symptoms listed below:
Post-exercise malaise: Sleep that doesn't alleviate weariness
A diminished capacity for memory or focus
Muscle pain; joint pain in several places without heat or swelling; cervical or axillary lymph node pain; sore throat; headache
PHYSICAL EXAMINATION: Although it is possible, painful lymphadenopathy is not necessary for diagnosis.
• Minimal outward signs.
TESTS FOR DIAGNOSIS AND INTERPRETATION
Lab
as required to take into account additional causes of weariness.
Imagining
Not advised.
Diagnostic Techniques and Other
clinical history-based diagnosis of exclusion, in accordance with the 1994 CDC criteria.
There are no pathological findings.
DIFFERENTIAL DIAGNOSIS: Lyme disease, depression, epilepsy, brucellosis, CMV, Epstein-Barr virus, and HIV infection
Brain tumors, tumors with paraneoplastic syndrome, and collagen-vascular diseases
MEDICAL CARE
supportive actions listed below.
MEDICATION Antidepressants along with other forms of treatment.
ADDITIONAL MEDICATION
Overall Actions
a focus on several treatment approaches with the aim of gradual progress over time.
Other Treatments
CBT, or cognitive behavioral treatment, is one (1) example.
A regimen called graded exercise treatment helps people with CFS avoid the "push-crash" cycle, which is characterized by overexertion followed by post-exertional malaise.
Throughout the day, schedule shorter bursts of moderate activity to lower the risk of "push-
crash" cycle. combines exercise and cognitive behavioral therapy. • Good sleep habits.
• Research on sleep.
ALTERNATIVE AND COMPLIMENTARY THERAPIES
• Deep breathing and other relaxing methods; • Massage Tai chi, yoga, and healing touch
Continuing Care Follow-Up Suggestions
It is advised to follow up with a multidisciplinary team of providers on a regular basis.
PROGNOSIS
• It takes a long time to get diagnosed (around five years on average). • Symptom improvement: 6–63%.
• Symptom resolution: 0–37%.
0 Comments
